Novozymes A/S (NVZMF)
OTC: NVZMF
· Real-Time Price · USD
67.38
0.00 (0.00%)
At close: Aug 12, 2025, 3:54 PM
67.38
0.00%
After-hours: Aug 13, 2025, 08:00 PM EDT
Novozymes A/S Balance Sheet Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 249.5M | 280M | 1.95B | 1.95B | 1.12B | 1.18B | 1.05B | 1.1B | 1.04B | 1.38B | 1.01B | 1.1B | 963M | 863M | 969M | 1.06B |
Short-Term Investments | 7M | 4M | 2.3M | n/a | 40M | 16M | 63M | 84M | 80M | 107M | 64M | 97M | 75M | 41M | 28M | 25M |
Long-Term Investments | n/a | 38.7M | 191.7M | 191.71M | 227M | 286M | 245M | 222M | 235M | 167M | 48M | -37M | -16M | 19M | 32M | 28M |
Other Long-Term Assets | 46.9M | 10M | 2.16B | 2.16B | 83M | 49M | 93M | 115M | 112M | 141M | 101M | 126M | 114M | 71M | 58M | 56M |
Receivables | 877.7M | 804.6M | 5.23B | 5.23B | 3.77B | 3.77B | 3.76B | 3.84B | 3.6B | 3.57B | 3.46B | 3.41B | 2.99B | 2.85B | 2.81B | 2.95B |
Inventory | 730.3M | 720.6M | 5.13B | 5.13B | 3.63B | 3.88B | 3.96B | 3.85B | 3.8B | 3.76B | 3.47B | 3.08B | 2.99B | 2.86B | 2.7B | 2.44B |
Other Current Assets | 81.4M | 70.2M | 1.18B | 1.18B | 947M | 616M | 4.3B | 801M | 618M | 619M | 619M | 732M | 880M | 621M | 592M | 558M |
Total Current Assets | 1.95B | 1.88B | 13.48B | 13.48B | 9.46B | 9.44B | 9.37B | 9.59B | 9.24B | 9.32B | 8.56B | 8.32B | 7.82B | 7.19B | 7.08B | 7.01B |
Property-Plant & Equipment | 2.92B | 2.97B | 21.38B | 21.38B | 12.32B | 12.68B | 12.34B | 12.14B | 12.07B | 11.96B | 11.25B | 10.44B | 10.19B | 9.76B | 9.68B | 9.74B |
Goodwill & Intangibles | 9.88B | 10.02B | 76.55B | 76.56B | 4.53B | 4.56B | 4.56B | 4.6B | 4.7B | 4.96B | 4.97B | 4.97B | 5.02B | 3.54B | 3.57B | 3.71B |
Total Long-Term Assets | 13.11B | 13.32B | 100.28B | 100.29B | 18.93B | 19.1B | 18.85B | 18.69B | 18.74B | 18.65B | 17.93B | 16.96B | 16.94B | 14.64B | 14.54B | 14.67B |
Total Assets | 15.06B | 15.2B | 113.77B | 113.77B | 28.39B | 28.54B | 28.23B | 28.28B | 27.98B | 27.98B | 26.5B | 25.28B | 24.77B | 21.83B | 21.62B | 21.68B |
Account Payables | 317.6M | 423.1M | 2.58B | 2.58B | 1.62B | 1.46B | 1.32B | 1.45B | 1.87B | 1.82B | 1.6B | 1.44B | 1.49B | 1.16B | 1.14B | 1.16B |
Deferred Revenue | n/a | n/a | n/a | n/a | 4.85B | 4.54B | 5.16B | 154M | 138M | 143M | 139M | 178M | 163M | 171M | 177M | 155M |
Short-Term Debt | 429.9M | 266.4M | 6.84B | 6.84B | 3.08B | n/a | n/a | n/a | 2.92B | n/a | n/a | n/a | 1.98B | n/a | n/a | n/a |
Other Current Liabilities | 294.9M | 337.9M | 2.75B | 2.75B | 1.61B | 108M | 3.61B | 5.38B | 1.36B | 5.15B | 5.3B | 5.2B | 3.21B | 2.92B | 3.45B | 3.6B |
Total Current Liabilities | 1.17B | 1.09B | 12.16B | 12.16B | 7.26B | 6.22B | 6.84B | 7.12B | 6.96B | 7.24B | 7.16B | 6.94B | 5.67B | 4.41B | 4.93B | 5.05B |
Long-Term Debt | 1.27B | 1.53B | 8B | 8B | 4.33B | n/a | n/a | n/a | 3.62B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 42.4M | 39.7M | 11.41B | 11.52B | 2.22B | 7.17B | 5.48B | 7.6B | 2.88B | 6.36B | 6.5B | 6.31B | 6.53B | 5.46B | 1.42B | 1.45B |
Total Long-Term Liabilities | 2.66B | 2.93B | 19.52B | 19.52B | 6.78B | 7.42B | 7.59B | 7.88B | 6.79B | 6.69B | 6.84B | 6.66B | 6.89B | 5.83B | 5.77B | 5.85B |
Total Liabilities | 3.83B | 4.02B | 31.68B | 31.68B | 14.04B | 13.65B | 14.43B | 15B | 13.76B | 13.93B | 14B | 13.59B | 12.56B | 10.25B | 10.7B | 10.9B |
Total Debt | 1.7B | 1.8B | 14.84B | 14.84B | 369M | 374M | 394M | 412M | 411M | 467M | 471M | 468M | 482M | 533M | 549M | 507M |
Common Stock | 125.6M | 125.6M | 125.7M | 937.65M | 562M | 562M | 562M | 562M | 562M | 562M | 562M | 564M | 564M | 564M | 564M | 570M |
Retained Earnings | 11.2B | 11.03B | 10.88B | 81.31B | 13.76B | 13.81B | 12.9B | 12.28B | 13.06B | 12.01B | 10.91B | 10.48B | 11.3B | 11.26B | 10.76B | 10.57B |
Comprehensive Income | n/a | n/a | -163.35M | -163.36M | -339M | 109M | -76M | 35M | 213M | 1.09B | 626M | 250M | -40M | -258M | -422M | -375M |
Shareholders Equity | 11.23B | 11.18B | 82.08B | 82.08B | 13.98B | 14.48B | 13.39B | 12.88B | 13.84B | 13.66B | 12.1B | 11.3B | 11.83B | 11.57B | 10.9B | 10.77B |
Total Investments | 41.1M | 42.7M | 191.7M | 191.71M | 267M | 302M | 308M | 306M | 315M | 274M | 112M | 60M | 59M | 60M | 60M | 53M |